Stocks
Funds
Screener
Sectors
Watchlists

Latest SPHERA FUNDS MANAGEMENT LTD. Stock Portfolio

SPHERA FUNDS MANAGEMENT LTD. Performance:
2024 Q3: 0.12%YTD: 4.5%2023: 6.79%

Performance for 2024 Q3 is 0.12%, and YTD is 4.5%, and 2023 is 6.79%.

About SPHERA FUNDS MANAGEMENT LTD. and 13F Hedge Fund Stock Holdings

SPHERA FUNDS MANAGEMENT LTD. is a hedge fund based in NEW YORK, NY. On 31-Mar-2022, the fund reported that it had an AUM (Regulated Assets under Management) of $789.8 Millions. In it's latest 13F Holdings report, SPHERA FUNDS MANAGEMENT LTD. reported an equity portfolio of $628.4 Millions as of 30 Sep, 2024.

The top stock holdings of SPHERA FUNDS MANAGEMENT LTD. are TEVA, , BBIO. The fund has invested 6.1% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 3.8% of portfolio in SANOFI.

The fund managers got completely rid off SALESFORCE INC (CRM), CYBIN INC (CYBN) and PALO ALTO NETWORKS INC (PANW) stocks. They significantly reduced their stock positions in BROADCOM INC (AVGO), KEZAR LIFE SCIENCES INC (KZR) and 4D MOLECULAR THERAPEUTICS IN (FDMT). SPHERA FUNDS MANAGEMENT LTD. opened new stock positions in NOVA LTD, VIKING THERAPEUTICS INC (VKTX) and CYBIN INC (CYBN). The fund showed a lot of confidence in some stocks as they added substantially to CAMTEK LTD, MARVELL TECHNOLOGY INC (MRVL) and ELEVATION ONCOLOGY INC (ELEV).

SPHERA FUNDS MANAGEMENT LTD. Annual Return Estimates Vs S&P 500

Our best estimate is that SPHERA FUNDS MANAGEMENT LTD. made a return of 0.12% in the last quarter. In trailing 12 months, it's portfolio return was 22.15%.

New Buys

Ticker$ Bought
nova ltd10,825,300
viking therapeutics inc8,424,410
cybin inc8,296,370
check point software tech lt7,753,850
biohaven ltd6,662,150
apellis pharmaceuticals inc6,225,780
ormat technologies inc5,255,200
cullinan therapeutics inc3,111,480

New stocks bought by SPHERA FUNDS MANAGEMENT LTD.

Additions

Ticker% Inc.
camtek ltd1,770
marvell technology inc338
elevation oncology inc227
teva pharmaceutical inds ltd169
intellia therapeutics inc108
sarepta therapeutics inc50.43
tower semiconductor ltd40.00
wix com ltd36.05

Additions to existing portfolio by SPHERA FUNDS MANAGEMENT LTD.

Reductions

Ticker% Reduced
broadcom inc-91.28
kezar life sciences inc-90.00
4d molecular therapeutics in-79.92
asml holding n v-71.32
adc therapeutics sa-70.09
compugen ltd-69.28
monte rosa therapeutics inc-68.51
lava therapeutics nv-60.16

SPHERA FUNDS MANAGEMENT LTD. reduced stake in above stock

Sold off

Ticker$ Sold
cybin inc-6,932,560
taboola.com ltd-2,295,800
catalyst pharmaceuticals inc-4,461,120
gossamer bio inc-200,121
akero therapeutics inc-3,322,400
upwork inc-1,257,750
icl group ltd-458,979
springworks therapeutics inc-2,647,030

SPHERA FUNDS MANAGEMENT LTD. got rid off the above stocks

Sector Distribution

SPHERA FUNDS MANAGEMENT LTD. has about 52.4% of it's holdings in Healthcare sector.

Sector%
Healthcare52.4
Others30.4
Technology11.2
Consumer Cyclical3.2
Communication Services2.8

Market Cap. Distribution

SPHERA FUNDS MANAGEMENT LTD. has about 32.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED30.5
MID-CAP18.1
MEGA-CAP17.9
LARGE-CAP14.3
SMALL-CAP14
MICRO-CAP4.5

Stocks belong to which Index?

About 47.1% of the stocks held by SPHERA FUNDS MANAGEMENT LTD. either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others52.9
RUSSELL 200026
S&P 50021.1
Top 5 Winners (%)%
CAPR
capricor therapeutics inc
233.6 %
KZR
kezar life sciences inc
116.0 %
APLT
applied therapeutics inc
51.8 %
VRDN
viridian therapeutics inc
50.2 %
PRAX
praxis precision medicines i
35.9 %
Top 5 Winners ($)$
PRAX
praxis precision medicines i
4.2 M
RARE
ultragenyx pharmaceutical in
4.0 M
TEVA
teva pharmaceutical inds ltd
2.1 M
META
meta platforms inc
2.1 M
APLT
applied therapeutics inc
1.6 M
Top 5 Losers (%)%
ELEV
elevation oncology inc
-56.1 %
FDMT
4d molecular therapeutics in
-32.6 %
APRE
aprea therapeutics inc
-32.4 %
ELYM
eliem therapeutics inc
-24.0 %
APLS
apellis pharmaceuticals inc
-23.3 %
Top 5 Losers ($)$
SRPT
sarepta therapeutics inc
-3.2 M
APLS
apellis pharmaceuticals inc
-1.9 M
JSPR
jasper therapeutics inc
-1.7 M
FDMT
4d molecular therapeutics in
-1.7 M
BIIB
biogen inc
-1.6 M

SPHERA FUNDS MANAGEMENT LTD. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SPHERA FUNDS MANAGEMENT LTD.

SPHERA FUNDS MANAGEMENT LTD. has 107 stocks in it's portfolio. About 31.7% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. PRAX was the most profitable stock for SPHERA FUNDS MANAGEMENT LTD. last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions